Priya Jegatheesan, MD Balaji Govindaswami, MBBS, MPH Division of Neonatology, Santa Clara Valley Medical Center, San Jose. August 12 th, 2014.

Slides:



Advertisements
Similar presentations
One Science = Early Childhood Pathway for Healthy Child Development Sentinel Outcomes ALL CHILDREN ARE BORN HEALTHY measured by: rate of infant mortality.
Advertisements

The Relationship of Adverse Childhood
Substance Exposed Newborns and the CPS Response January 30, 2015 Handle with C.A.R.E. Initiative People helping people triumph over poverty, abuse and.
Neonatal Abstinence Syndrome: Taking Care of Mom and Baby Heather Rodman, PharmD PGY-2 Pediatric Pharmacy Resident Peyton Manning Children’s Hospital St.
Effective Risk Management Strategies in Outpatient Methadone Treatment: Clinical Guidelines and Liability Prevention Curriculum Module 9 Special Populations.
Moms on Meds Substance Abuse During Pregnancy: Jennifer Anderson Maddron, M.D.
Putting the Pieces Together Perspectives from an Opioid Addiction Treatment Program.
Addressing Trauma in Our Communities
Neonatal Abstinence Syndrome. Risks for developing NAS Opioids – Opiate derivatives, interact with mu-opioid receptor Abstinence syndrome (withdrawal)
Identifying the Prevalence of Perinatal Substance Abuse in Santa Clara County September 2004 Karen Miyamoto, PHN Maternal, Child & Adolescent Health Program.
Many Disciplines: One Goal. Care of the Drug Exposed Newborn Kelly Burch, PharmD NICU Conference October 26, 2010 St. John’s Mercy Children’s Hospital.
2013 Alaska Behavioral Risk Factor Surveillance System Adverse Childhood Experiences of Alaskan Adults.
Treatment Of Medical, Psychiatric, and Substance Use Co-morbidities In People Infected With HIV Who Use Drugs Frederick L. Altice (US, Malaysia, Ukraine)
Facts In 2008, an estimated 20.1 million Americans aged 12 or older were current (past-month) illicit drug users. (8.0% of the population) million.
1 Behavioral Health/Juvenile Justice (BH/JJ) Evaluation Report ( ) Presented by Jeff Kretschmar, Ph.D. Project Director: Institute for the Study.
Alcoholism and Substance Abuse. Focus Alcoholism.
Setting the Standard for Psychiatric & Addiction Services Inpatient Treatment for Adolescents Jeanne Resendez Referral Development Manager.
HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program.
Alcoholism and Substance Abuse. Focus Alcoholism.
Women, Pregnancy and Substance Use Dependence Maternal and Child Health Conference 22 nd February 2013 Theresa Lynch Manager – Women’s Alcohol and Drug.
 Most drug use starts and peaks during adolescence  76.5% of all teens (
Addressing Perinatal Substance Use, Intimate Partner Violence & Mood Disorder Screening in a CPSP Setting Using a Collective Impact Model.
Linda Chamberlain, PhD MPH IPV and Sexually Transmitted Infections/HIV MENU Overview Regional and Local Data The Impact of IPV on Women’s Health IPV and.
Diagnosis And Treatment Of Prescription Opioid Dependence Steven W. Clay, D.O. Associate Professor, Department of Family Medicine Ohio University College.
Biology of Substance Abuse
Adverse Childhood Experiences and their Relationship to
The Relationship of Adverse Childhood Experiences to Adult Health Status Presentation to MCAH Committee December2, 2010 Edwin Ferran Director of Learning.
Substance Use & Abuse in Pregnancy Janet L. Mitchell, M.D., M.P.H., F.A.C.O.G. Consultant on Women’s Health Addiction Research & Treatment Corporation.
2013 Alaska Behavioral Risk Factor Surveillance System Adverse Childhood Experiences of Alaskan Adults.
Current Trends In Identifying And Treating Newborns With Withdrawal Syndromes 6/24/2010.
Pregnancy and Drug Abuse Eva Janecek-Rucker. Learning Objectives 1.To develop a knowledge base of the effects of substances of abuse (e.g., alcohol, cocaine,
Chapter 16 Addictive Disorders. Abuse  Use of a substance that falls outside of medical necessity or social acceptance resulting in adverse effects to.
Treating Pregnant Opioid Dependent Women: Examining Buprenorphine and Methadone Hendrée E. Jones, Ph.D. Associate Professor Department of Psychiatry and.
The Counseling Center, Inc. Devoted to the prevention and treatment of alcoholism and other drug addictions. We promote opportunities for individuals and.
Child Maltreatment in the Context of Substance Abuse.
Adverse Childhood Experiences and their Relationship to Adult Well-being, Disease, and Death : Turning gold into lead A collaborative effort between Kaiser.
Difficult conversations in the Neonatal Period
Incorporating Preconception Health into MCH Services
Difficult conversations in the Neonatal Period Opiate Use and Breastfeeding.
Special patient groups Module 5. Introduction Worldwide, the majority of people in substitute treatment are men between Even they do not form a.
Trauma and Trauma Informed Care. Trauma  What is trauma?  How prevalent is trauma ?  How long does it last?  Why should we be aware of it?
Overview of the Adverse Childhood Experiences (ACE) Study Robert F. Anda, MD, MS ACE Study Co-Principal Investigator Co-Founder ACE Interface
Brain diseases: Substance abuse and co-occurring disorders Mark Publicker, MD FASAM.
Substance Abuse Spring Substance-Related Disorders Substance abuse Substance dependence –Tolerance –Withdrawal Substance intoxication 2 Define substance.
Cyndie Meyer, R.D. Program Manager for Chronic Disease Prevention Clark County Public Health From Adversity to Resilience.
Cleveland Municipal Drug Court: SAMHSA CSAT Adult Treatment Drug Court Grant Dr. Margaret Baughman Madison Wheeler, BS Paul Tuschman, BA Begun.
September 2015 PREGNANCY.  Awareness of the range of substance use disorders in pregnancy  Understand how different substances affect the fetus  Identification.
Erika McElroy, Ph.D. Associate Director of Behavioral Health Services Kempe Center for the Prevention and Treatment of Child Abuse and Neglect University.
Neonatal Abstinence Syndrome
Specific issues in drug use and pregnancy. Pregnant women who use drugs (RCOG, 2010) One of the challenges for pregnant women who use drugs is that they.
Care of the Neonate with Prenatal Opioid Exposure – Advanced Practice
ADVERSE CHILDHOOD EXPERIENCES AND BEHAVIORAL HEALTH
Medication Assisted Treatment and Pregnancy
Substance Exposed Newborns: Addressing Substance Use Disorder
Nicole Lind Western Health
US Census Data Ortman, Jennifer M., Victoria A. Velkoff, and Howard Hogan. An Aging Nation: The Older Population in the United States, Current Population.
Drug addiction: Therapeutic problems in everyday clinical practice
Screening and Referral
Neonatal Abstinence Syndrome: An emerging issue for Part C systems?
ICAAP & IEA host a screening and discussion of Paper Tigers
Delaware Dialogue: Addressing Substance Abuse DHMIC Summit 2017
Neonatal Abstinence Syndrome
Substance abuse reveiw
Trauma Informed Care, For All
WisPQC Standardized Protocol Webinar for NAS/NOWS Initiative
Understanding the Effects of Trauma on Health
This product was funded under a cooperative agreement from the Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Substance.
Vision Transformative collaboration that fosters resilient self-sustaining Recovery Communities. Mission To develop and sustain measurable solutions that.
Gender Issues and Addiction
Treating and Managing Opioid Use Disorder in Pregnancy
Presentation transcript:

Priya Jegatheesan, MD Balaji Govindaswami, MBBS, MPH Division of Neonatology, Santa Clara Valley Medical Center, San Jose. August 12 th, 2014

Objective Scope of the problem of substance abuse Biology of addiction in adult vs. newborns Challenges in the care of newborns exposed to substances in utero

Substance Abuse – Global Problem Alcohol – causes 6% of global death Drugs % adults use drugs 1 % of deaths attributable to drugs Annual Prevalence and number of illicit drug users at the global level, 2010 Prevalence (%)Number (thousands) LowHighLowHigh Cannabis ,420224,490 Opioids ,38036,120 Opiates ,98020,990 Cocaine ,20019,510 Ampheta mine– type ,34052,540 Ecstasy ,48028,120 Any illicit ,000300,000

Substance Abuse – National Problem: SAMHSA m (9%) used illicit substance in the last month Most common is Marijuana – 7% Methamphetamine % Non-medically used prescription drugs 2.6% Dependence – 8.5% Pregnant women – 5.6% used illicit drugs (lower than in non-pregnant (10.7%) population; y – 18% DUHresults2012.pdf

Maternal co-morbidities Psychiatric illness Depression, Anxiety disorders 45% Axis 1 diagnosis, 75% Axis 2 diagnosis Psychosocial Lower socio-economic status & educational level Adverse Childhood Experiences: Abuse – emotional, physical, sexual Dysfunctional household Substance abuse Mental illness Domestic violence Incarceration separation

Maternal co-morbidities Infections – HIV, Hep B, Hep C Transmission IV, blood products, sexual transmission Risk Factors IV drug use Risky sexual related behavior Risky drug related behavior Immunocompromised

Biology of Addiction – Reward Pathway

Biology of Addiction VTA – dopaminergic neurons tell the individual if the stimuli is rewarding or aversive NA – GABAergic neurons mediate the rewarding effect Amygdala – establishes conditioned learning, learns associations to environmental cues and the rewarding experience. Hippocampus – establishes memory associated with reward experiences Pre-frontal cortex – glutamatergic neurons controls the executive function that mediates drug seeking behavior.

Biology of Withdrawal in Newborns Physical signs of withdrawal from opiates is mediated by Neuro Epinephrine Neurons in Locus Ceruleus in Mid Brain. LC – Neurons have Mu receptors, Alpha 2 Adrenergic receptors that decrease NE via adenyl cyclase – cAMP - PKA

Biology of Withdrawal in Newborns

Challenges in Care Universal Screening vs. Risk Based Scoring; Toxicology: Urine vs. Meconium vs. Cord vs. Hair Score for Withdrawal - which score, when to score, how to score, when to treat Treatment options only for opiate withdrawal: opiates vs. phenobarb vs. clonidine Breastfeed or not Discharge planning difficulties: home with mom or foster care

Screening for Substance Exposure Universal Standardized questionnaire Non-judgemental Trauma informed care 5Ps, … etc. Toxicology Urine Meconium Hair / Umbilical cord Legal Implications Consent CPS referral

Withdrawal Scores Only for opiate withdrawal Finnegan Score vs. Modified Standardized, inter rater reliability – staff education When to score – before or after feeds Polysubstance abuse may impact the scores (nicotine withdrawal etc.) however it is used specifically to treat opiate withdrawal Encourage Parental involvement Optimize non-pharmacological measures

Medical treatment for NAS Opiate agonist – Morphine / methadone acts on Mu receptors Clonidine – Alpha 2 adrenergic agonist – suppresses noradrenergic mediated sympathomimetic symptoms of withdrawal Phenobarbital - GABAergic agonist, but also blocks AMPA (excitatory) receptor, also non-specific to other receptors in brain Ondansetron – 5HT antagonist – decreases the withdrawal symptoms in animals / adults

Breastfeeding Uncertain pharmacokinetics of illicit drugs in mothers and newborns Adulterants in the drugs Variable excretion into breastmilk Co-morbid psychiatric illness Psychiatric medications Viral infections that are contraindications (HIV, HSV with active lesions on the breast)

Recommendations from ABM and AAP

Challenges with breastfeeding Complicated recommendations Medical team often ineffective in making social assessments Medical drugs vs. Illicit drugs Marijuana – medical / non-medical When in hospital, do you initiate breastfeeding and then evaluate, pump and dump, discourage ……..

Discharge Planning Difficult social situation, lack of a support system Unstable / unsafe home environment Lack of adequate residential treatment programs for mother and babies Outpatient Perinatal Substance Abuse Programs Foster care vs. discharge with biological mother with CPS supervision Breastfeeding but at still at risk of relapse

Acknowledgement Substance exposed mothers and newborns at SCMVC SCVMC MCH Staff Perinatal Substance Abuse Program at SC County Santa Clara First Five VMC Foundation VON iNICQ Collaborative NIH Funding for Prevention of NAS study SAMHSA Advisory group – MAT NAS